Popular on Amzeal
- What If Help Could Come Before the Fall? - 110
- Bruce C. Barnes Joins Summit's Board of Advisors - 109
- Some Music for Donald's Bad Day
- New AI Platform Helps Individuals Pivot After Job Loss
- 'Wild Hermit Wellness' Has Achieved Bestseller Status in Just 2 Months Since Launch Of Organic Skincare Line
- Frost Locker: New Research Reveals Mild Cold—Not Extreme Cold—Delivers Real Health Benefits of Cold Therapy
- GitKraken Launches Insights to Help Engineering Leaders Quantify AI Impact and Improve Developer Experience
- SwagHer Society Launches to Help Black Women Be Seen and Supported
- Arc Longevity Sells Out Debut Women's Creatine Gummy
- Bookmakers Review Launches Betting Insights on NBC's "The Voice: Battle of Champions"
Similar on Amzeal
- North Wind Selects Nor-Tech Again for Next-Generation HPC Cluster
- Emeritus Addresses Hospital Bed Shortages with Smart Storage Solutions
- Fulton County & Grow Your World Amplify Atlanta Youth Through the Youth Audio Collective
- The Lashe® Announces Exclusive November Savings for Lash and Beauty Professionals
- November is Lung Cancer Awareness Month: Screening Saves Aims to Increase Access to Lung Screenings in NC
- Valeo Health Leads a New Era of Longevity and Preventive Health in the UAE
- Wohler announces three SRT monitoring enhancements for its iVAM2-MPEG monitor and the addition of front panel PID selection of A/V/subtitle streams
- 5,000 Australians Call for Clarity: NaturismRE's Petition Reaches Major Milestone
- Cartwheel Signs Letter of Intent to License Clearsight Therapeutics' Novel Pink Eye Treatment for 2027 Portfolio Expansion
- Vet Maps Launches National Platform to Spotlight Veteran-Owned Businesses and Causes
CCHR: For Prevention, Families Deserve Truth From NIH Study on Psychiatric Drugs
Amzeal News/10610180
Communities deserve answers on the potential role psychotropic drugs and treatments may have in senseless acts of violence—an issue too long suppressed by vested interests.
LOS ANGELES - Amzeal -- By CCHR International
Families and communities deserve answers about the potential role psychiatric drugs may play in senseless acts of violence—an issue suppressed for decades by vested interests. The Citizens Commission on Human Rights International (CCHR) is urging that the National Institutes of Health (NIH) study on psychotropic drugs and violence be given the full weight it deserves, warning that dismissing it would betray the public's right to safety and truth.
The NIH has been directed to investigate studies to shed light on the link between psychiatric drugs, particularly SSRI (Selective Serotonin Reuptake Inhibitor) antidepressants, and violence. CCHR President Jan Eastgate stressed: "The significance of this lies in its potential to open a conversation long silenced—how mind-altering drugs, prescribed to millions, may contribute to acts of senseless violence, from shootings to stabbings and assaults that devastate families."
Cocaine, methamphetamine, and alcohol are widely recognized as risk factors for aggression. "Why should prescription psychotropics be treated differently? Families deserve truth, not excuses," Eastgate added.
Tennessee in 2025 mandated toxicology testing for psychotropic drugs in autopsies after certain mass shootings—a landmark policy CCHR says should be expanded nationwide to cover all mass acts of violence.[1] A Florida Senator has announced plans to file a bill requiring disclosure of whether perpetrators of mass or terroristic violence had taken antidepressants, citing public safety concerns.
In 2000, the New York State Senate proposed tracking violent crimes committed by individuals tested for psychotropic drugs. The bill stalled in committee, but had it passed, a reporting system would already be in place.
Concerns are not new. In 1989, at a Kentucky coroner's inquest, a psychiatrist testified that an antidepressant influenced a workplace shooting in which eight people were killed. Since then, medical experts across the U.S. and internationally have raised alarm over violent acts linked to psychiatric drugs, while the industry has resisted scrutiny.
More on Amzeal News
Regulators have long issued warnings:
The Violence Project's Mass Shooter Database reports at least 24% of shooters had been on psychotropics—a figure likely underestimated due to limited access to medical records.[6] Independent researchers, including Professors Peter C. Gøtzsche and David Healy, have published data showing increased aggression linked to SSRIs.[7]
The FDA admitted in 2007 that all patients on antidepressants should be closely monitored for agitation, hostility, aggression, or unusual behavior.[8] Professor Healy has explained that drug-induced agitation is a major causal factor in suicide and violence, with about 5% of patients dropping out of trials for this reason—ten times the placebo rate.[9] Applied to 45 million Americans on antidepressants, that risk could potentially affect 2.25 million people.
Withdrawal adds further risks. The UK Royal College of Psychiatrists warns that stopping antidepressants can trigger anger, agitation, suicidal impulses, or akathisia—an intense inner restlessness linked to violence. These effects may persist for weeks, months, or longer.[10] "Too often, such reactions are misrepresented by vested interests as a perpetrator merely stopping treatment, rather than serious drug-induced withdrawal effects," Eastgate said.
Recent tragedies highlight the issue:
While not every individual reacts violently, evidence shows that a subset does—and families deserve to be informed of the risks.
More on Amzeal News
Violence is not a symptom of mental illness. As Dr. Jonathan Metzl of Vanderbilt University notes, no psychiatric diagnosis includes homicidal behavior. Substance-induced states, however, are well-recognized causes of violence.
Other influences also matter. Programs such as "death education" and court-mandated anger management have shaped violent behavior in some cases. Two U.S. school shooters in Columbine, Colorado—one taking an SSRI—had been instructed in class to imagine and write about their own deaths. One described a shooting spree—then weeks later, enacted it.[11]
Eastgate emphasized: "Investigating this issue does not mean excusing crime. It means transparency, accountability, and willingness to examine all possible causes, rather than protecting commercial interests. To ignore prescription psychotropics despite regulatory warnings and clinical evidence is reckless."
CCHR argues that honest inquiry is essential:
CCHR has published a documented report, Psychiatric Drugs: Create Violence & Suicide—School Shootings and Other Acts of Senseless Violence.
CCHR is a non-profit mental health industry watchdog founded in 1969 by the Church of Scientology and professor of psychiatry, Dr. Thomas Szasz. For more than five decades, it has investigated and exposed psychiatric abuse, leading to reforms and protections worldwide.
Sources:
[1] www.thegatewaypundit.com/2025/04/ablechild-tennessee-sets-national-precedent-passage-ablechild-bill/
[2] "Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – Nov. 2005
[3] www.canada.ca/en/news/archive/2004/06/health-canada-advises-canadians-stronger-warnings-ssris-other-newer-anti-depressants.html
[4] Australian Therapeutic Goods Administration "Product Information safety updates"
[5] Ibid.
[6] www.theviolenceproject.org/mass-shooter-database/
[7] www.madinamerica.com/2024/08/violence-caused-by-antidepressants-ignored-once-again-by-psychiatrists/; www.eventbrite.com/e/antidepressants-and-homicide-automatism-spectrum-disorders-tickets-1020994190107
[8] www.cchrint.org/2024/10/11/cchr-wants-increased-consumer-awareness-about-prescriptions-for-violence/; www.bmj.com/content/358/bmj.j3697
[9] www.bmj.com/content/358/bmj.j3697
[10] www.cchrint.org/2021/04/06/antidepressant-withdrawal-warning-vital/; www.researchgate.net/publication/335329642_Antidepressant_withdrawal_-_the_tide_is_finally_turning
[11] www.washingtontimes.com/news/2002/aug/18/20020818-040825-5515r/
Families and communities deserve answers about the potential role psychiatric drugs may play in senseless acts of violence—an issue suppressed for decades by vested interests. The Citizens Commission on Human Rights International (CCHR) is urging that the National Institutes of Health (NIH) study on psychotropic drugs and violence be given the full weight it deserves, warning that dismissing it would betray the public's right to safety and truth.
The NIH has been directed to investigate studies to shed light on the link between psychiatric drugs, particularly SSRI (Selective Serotonin Reuptake Inhibitor) antidepressants, and violence. CCHR President Jan Eastgate stressed: "The significance of this lies in its potential to open a conversation long silenced—how mind-altering drugs, prescribed to millions, may contribute to acts of senseless violence, from shootings to stabbings and assaults that devastate families."
Cocaine, methamphetamine, and alcohol are widely recognized as risk factors for aggression. "Why should prescription psychotropics be treated differently? Families deserve truth, not excuses," Eastgate added.
Tennessee in 2025 mandated toxicology testing for psychotropic drugs in autopsies after certain mass shootings—a landmark policy CCHR says should be expanded nationwide to cover all mass acts of violence.[1] A Florida Senator has announced plans to file a bill requiring disclosure of whether perpetrators of mass or terroristic violence had taken antidepressants, citing public safety concerns.
In 2000, the New York State Senate proposed tracking violent crimes committed by individuals tested for psychotropic drugs. The bill stalled in committee, but had it passed, a reporting system would already be in place.
Concerns are not new. In 1989, at a Kentucky coroner's inquest, a psychiatrist testified that an antidepressant influenced a workplace shooting in which eight people were killed. Since then, medical experts across the U.S. and internationally have raised alarm over violent acts linked to psychiatric drugs, while the industry has resisted scrutiny.
More on Amzeal News
- North Wind Selects Nor-Tech Again for Next-Generation HPC Cluster
- ZEELOOL's Black Friday Sale Starts Early with Up to 80% Off Frames
- UV Weathering Test Chamber vs Xenon Arc Test Chamber: What's the Right Solution for Your Products
- Emeritus Addresses Hospital Bed Shortages with Smart Storage Solutions
- Fulton County & Grow Your World Amplify Atlanta Youth Through the Youth Audio Collective
Regulators have long issued warnings:
- The Food and Drug Administration (FDA) has logged at least 1,530 reports of homicide or homicidal ideation associated with psychiatric drugs.
- FDA advisories (2004, 2005) highlighted risks of agitation, hostility, and suicidal behavior on antidepressants. It also warns of homicidal ideation with one SSRI.[2]
- Health Canada warned of SSRIs' "potential for harm, including suicidal thoughts and the onset or worsening of agitation-type adverse events."[3]
- Australian regulators linked stimulants such as dextroamphetamine and atomoxetine to homicidal thoughts.[4]
- The European Medicines Agency reported increased aggression in children and adolescents taking SSRIs.[5]
- FDA Black Box Warnings already acknowledge suicidal thoughts on drugs such as the ADHD drug Strattera (atomoxetine hydrochloride) and antidepressants.
The Violence Project's Mass Shooter Database reports at least 24% of shooters had been on psychotropics—a figure likely underestimated due to limited access to medical records.[6] Independent researchers, including Professors Peter C. Gøtzsche and David Healy, have published data showing increased aggression linked to SSRIs.[7]
The FDA admitted in 2007 that all patients on antidepressants should be closely monitored for agitation, hostility, aggression, or unusual behavior.[8] Professor Healy has explained that drug-induced agitation is a major causal factor in suicide and violence, with about 5% of patients dropping out of trials for this reason—ten times the placebo rate.[9] Applied to 45 million Americans on antidepressants, that risk could potentially affect 2.25 million people.
Withdrawal adds further risks. The UK Royal College of Psychiatrists warns that stopping antidepressants can trigger anger, agitation, suicidal impulses, or akathisia—an intense inner restlessness linked to violence. These effects may persist for weeks, months, or longer.[10] "Too often, such reactions are misrepresented by vested interests as a perpetrator merely stopping treatment, rather than serious drug-induced withdrawal effects," Eastgate said.
Recent tragedies highlight the issue:
- U.S. and European incidents in 2025 revealed perpetrators with histories of psychiatric drug treatment or active prescriptions.
- Investigators in Sweden concluded that one mass killer acted under the influence of amphetamine and sedative drugs.
- Reports from Tennessee, Florida, New York, and Germany similarly documented psychiatric drugs in connection with acts of mass violence.
While not every individual reacts violently, evidence shows that a subset does—and families deserve to be informed of the risks.
More on Amzeal News
- 2026 Oscars Betting Odds: One Battle After Another Favored for Best Picture
- Allen Field Co., Inc. Components Selected for Esko ArtiosCAD 3D Component Library
- Perle IRG Routers Deliver Reliable Connectivity for Smart Transit Systems
- Thirteen Reasons Why Gyminny Kids Is San Diego's Best Gymnastics Gym
- Heritage At Manalapan - A New Luxury Single Family Home Community Coming Late 2025
Violence is not a symptom of mental illness. As Dr. Jonathan Metzl of Vanderbilt University notes, no psychiatric diagnosis includes homicidal behavior. Substance-induced states, however, are well-recognized causes of violence.
Other influences also matter. Programs such as "death education" and court-mandated anger management have shaped violent behavior in some cases. Two U.S. school shooters in Columbine, Colorado—one taking an SSRI—had been instructed in class to imagine and write about their own deaths. One described a shooting spree—then weeks later, enacted it.[11]
Eastgate emphasized: "Investigating this issue does not mean excusing crime. It means transparency, accountability, and willingness to examine all possible causes, rather than protecting commercial interests. To ignore prescription psychotropics despite regulatory warnings and clinical evidence is reckless."
CCHR argues that honest inquiry is essential:
- Families who lost loved ones deserve clear answers.
- Communities living in fear need prevention strategies grounded in science, not industry spin.
- Policymakers must have accurate data to legislate effectively.
CCHR has published a documented report, Psychiatric Drugs: Create Violence & Suicide—School Shootings and Other Acts of Senseless Violence.
CCHR is a non-profit mental health industry watchdog founded in 1969 by the Church of Scientology and professor of psychiatry, Dr. Thomas Szasz. For more than five decades, it has investigated and exposed psychiatric abuse, leading to reforms and protections worldwide.
Sources:
[1] www.thegatewaypundit.com/2025/04/ablechild-tennessee-sets-national-precedent-passage-ablechild-bill/
[2] "Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – Nov. 2005
[3] www.canada.ca/en/news/archive/2004/06/health-canada-advises-canadians-stronger-warnings-ssris-other-newer-anti-depressants.html
[4] Australian Therapeutic Goods Administration "Product Information safety updates"
[5] Ibid.
[6] www.theviolenceproject.org/mass-shooter-database/
[7] www.madinamerica.com/2024/08/violence-caused-by-antidepressants-ignored-once-again-by-psychiatrists/; www.eventbrite.com/e/antidepressants-and-homicide-automatism-spectrum-disorders-tickets-1020994190107
[8] www.cchrint.org/2024/10/11/cchr-wants-increased-consumer-awareness-about-prescriptions-for-violence/; www.bmj.com/content/358/bmj.j3697
[9] www.bmj.com/content/358/bmj.j3697
[10] www.cchrint.org/2021/04/06/antidepressant-withdrawal-warning-vital/; www.researchgate.net/publication/335329642_Antidepressant_withdrawal_-_the_tide_is_finally_turning
[11] www.washingtontimes.com/news/2002/aug/18/20020818-040825-5515r/
Source: Citizens Commission on Human Rights International
Filed Under: Consumer, Medical, Health, Government, Science, Citizens Commission On Human Rights, CCHR International
0 Comments
Latest on Amzeal News
- $76 Million in Gold & Silver Holdings and Expanding Production — Pioneering the Future of Gold: Asia Broadband Inc. (Stock Symbol: AABB) is Surging
- Wohler announces three SRT monitoring enhancements for its iVAM2-MPEG monitor and the addition of front panel PID selection of A/V/subtitle streams
- Schemawriter.ai launches WordPress plugin as industry leaders confirm - schema markup is critical
- 20 Million Financing to Accelerate Growth and Advance Digital Asset Strategy Secured for Super League (N A S D A Q: SLE)
- uCAR Trading Launches goldsilbermarkt.de, a New Online Shop for Precious Metals
- Phinge to be in Las Vegas the Week of CES: Developers, Come Meet the CEO and Preview how Netverse's Verified App-less Platform and AI will Benefit You
- Webinar Announcement: Reputational Risk Management in Internal Investigations: Controlling the Narrative Before, During, and After a Crisis
- Taking on the Multi-Billion-Dollar Swipe Industry: AI Curates Who You Meet—IRL over brunch
- 5,000 Australians Call for Clarity: NaturismRE's Petition Reaches Major Milestone
- High-Tech M&A Market Intelligence: Strategic Acquisitions Across Critical Sectors
- Cartwheel Signs Letter of Intent to License Clearsight Therapeutics' Novel Pink Eye Treatment for 2027 Portfolio Expansion
- NOYACK Launches AI-Powered Financial Education Platform to Help Millennials and Gen Z Grow Net Worth
- Experiture Unveils The Campaign Wizard: Built to Help Marketers Take Back Their Time, Focus, and Creative Energy
- New vertical screen game HOT LOCKS keeps your players engaged
- Vet Maps Launches National Platform to Spotlight Veteran-Owned Businesses and Causes
- $114.6 Million in Revenues, Up 54%: Uni-Fuels Holdings (N A S D A Q: UFG) Accelerates Global Expansion Across Major Shipping Hubs as Demand Surges
- Dental Care Solutions Unveils New Website for Enhanced Patient Engagement
- TradingHabits.com Launches to Support Day Trader Well-being
- Apptium Achieves SOC 2 Type 1 and Multiple ISO Certifications
- Aeternum Announces Alpha Launch: A Private Digital Vault to Preserve Family Legacies for Generations

